Breaking News Instant updates and real-time market news.

AGN

Allergan

$227.94

3.95 (1.76%)

, TBRA

Tobira Therapeutics

$40.28

0.18 (0.45%)

08:01
10/19/16
10/19
08:01
10/19/16
08:01

Allergan, Tobira Therapeutics announce early termination of HSR waiting period

Allergan (AGN) and Tobira Therapeutics (TBRA) announced that the U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, with respect to Allergan's pending acquisition of Tobira. The early termination of the HSR waiting period satisfies one of the conditions to the closing of the pending acquisition, which remains subject to other customary closing conditions. Both companies expect the transaction to be completed by the end of 2016.

AGN

Allergan

$227.94

3.95 (1.76%)

TBRA

Tobira Therapeutics

$40.28

0.18 (0.45%)

  • 26

    Oct

  • 02

    Nov

  • 06

    Nov

AGN Allergan
$227.94

3.95 (1.76%)

09/21/16
GABE
09/21/16
NO CHANGE
GABE
Buy
Gabelli questions if Allergan could target Gilead next
Gabelli analyst Kevin Kedra said that "like most" he was surprised at the price paid and the strategic fit of Allergan's (AGN) deal to buy Tobira Therapeutics (TBRA), but wonders if Allergan CEO Brent Saunders is "playing chess while the market is playing checkers" and could be preparing a bid for Gilead (GILD). After Allergan's "very loud statement about its commitment to NASH and liver disease," a deal for Gilead, the leading company in liver disease and "one of the cheapest companies in pharma/biotech," would appear to make more sense, Kedra tells investors, adding that an acquisition of Gilead at a price of $115 per share would be "highly accretive" for Allergan. The analyst keeps a Buy rating on Allergan shares.
09/22/16
BERN
09/22/16
NO CHANGE
BERN
Allergan acquisitions positive, says Bernstein
After Allergan bought two companies with NASH drugs and the stock fell, Bernstein analyst Aaron Gal says the acquisitions were viewed as expensive. Gal says "it makes almost no difference" if the deals were expensive, as the important issue is whether the products succeed. He believes that the market would never penalize Roche or Celgene for similar deals, and he thinks this indicates that Allergan is "misvalued." He says that Allergan is his "high conviction buy" stock and keeps a $335 price target on the shares.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.
10/14/16
LEER
10/14/16
NO CHANGE
Target $294
LEER
Outperform
Leerink positive on Allergan ahead of Restasis patent decision
Leerink analyst Jason Gerberry is positive on Allergan's franchise outlook as he believes the company will either maintain a double-digit top-line" growth pharma" trajectory or alternatively institute a dividend, and will prevail in the ongoing Restasis patent challenge. Gerberry likes Allergan's underlying growth trends of the gastro and derm franchises and pipeline optionality, and reiterates an Outperform rating and $294 price target on the shares.
TBRA Tobira Therapeutics
$40.28

0.18 (0.45%)

09/20/16
STFL
09/20/16
NO CHANGE
Target $6
STFL
Buy
Stifel says Conatus emricasan an interesting asset amid increased focus on NASH
Following Allergan's (AGN) acquisition of small-cap NASH play Tobira (TBRA), Stifel analyst Stephen Willey notes there are some "interesting" similarities between Conatus (CNAT) and the latter. However, the analyst points out that the clearest distinctions between the two are Conatus' emphasis on some of the downstream consequences of NASH fibrosis and the amount of meaningful clinical data generated to date. Willey still thinks Conatus' emricasan is an interesting asset, but urges investors seeking Tobira-like premiums to exercise a level of caution. He reiterates a Buy rating and $6 price target on Conatus' shares. In afternoon trading, shares of Conatus have gained about 20% to $2.10.
09/21/16
BARD
09/21/16
NO CHANGE
Target $332
BARD
Outperform
Intercept undervalued based on Allergan's upfront payment for Tobira, says Baird
Baird analyst Brian Skorney is positive on the yesterday's merger activity in the NASH space, specifically Allergan's (AGN) offer to buy Tobira Therapeutics (TBRA). Based on the upfront payment to Tobira from Allergan, Skorney said he can't help but question whether Intercept (ICPT) shares are undervalued. Skorney reiterated his Outperform rating on Intercept shares and keeps a $332 price target on the stock.
09/21/16
CANT
09/21/16
DOWNGRADE
CANT
Hold
Tobira Therapeutics downgraded to Hold from Buy at Cantor
Cantor analyst Elemer Piros downgraded Tobira (TBRA) after the company agreed to be acquired by Allergan (AGN). Target to $42 from $19.

TODAY'S FREE FLY STORIES

02:30
01/16/18
01/16
02:30
01/16/18
02:30
General news
FX Update: The dollar has settled above yesterday's trend lows »

FX Update: The dollar has…

01:45
01/16/18
01/16
01:45
01/16/18
01:45
General news
FX Action: USD-JPY has lifted to the upper 110.0s »

FX Action: USD-JPY has…

F

Ford

$13.23

0.07 (0.53%)

, FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

20:06
01/15/18
01/15
20:06
01/15/18
20:06
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

F

Ford

$13.23

0.07 (0.53%)

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

SFTBY

SoftBank

$40.35

-0.705 (-1.72%)

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

TSLA

Tesla

$336.22

-1.73 (-0.51%)

BMWYY

BMW

$36.52

0.835 (2.34%)

TM

Toyota

$137.20

0.29 (0.21%)

GM

General Motors

$44.07

-0.12 (-0.27%)

VLKAY

Volkswagen

$44.34

1.065 (2.46%)

FB

Facebook

$179.37

-8.4 (-4.47%)

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

AAPL

Apple

$177.09

1.81 (1.03%)

NFLX

Netflix

$221.23

3.99 (1.84%)

VIVHY

Vivendi

$28.42

-1.035 (-3.51%)

BEN

Franklin Resources

$44.53

0.59 (1.34%)

PFE

Pfizer

$36.54

-0.02 (-0.05%)

AMGN

Amgen

$185.04

3.08 (1.69%)

ABBV

AbbVie

$100.34

1.07 (1.08%)

LLY

Eli Lilly

$86.98

0.59 (0.68%)

BMY

Bristol-Myers

$62.81

0.34 (0.54%)

JNJ

Johnson & Johnson

$145.76

0.97 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 26

    Jan

  • 30

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 03

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 05

    Mar

  • 18

    Mar

  • 25

    Mar

  • 30

    Apr

  • 17

    May

  • 28

    May

AAPL

Apple

$177.09

1.81 (1.03%)

19:29
01/15/18
01/15
19:29
01/15/18
19:29
Periodicals
China consumer group seeking answers from Apple on slowing iPhones, Reuters says »

A Chinese consumer group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

TWX

Time Warner

$92.05

0.16 (0.17%)

, CMCSA

Comcast

$42.44

-0.16 (-0.38%)

18:52
01/15/18
01/15
18:52
01/15/18
18:52
Hot Stocks
Box Office Battle: 'Jumanji' wins weekend again »

Sony's (SNE)…

TWX

Time Warner

$92.05

0.16 (0.17%)

CMCSA

Comcast

$42.44

-0.16 (-0.38%)

CMCSK

Comcast

SNE

Sony

$50.03

-0.25 (-0.50%)

FOX

21st Century Fox

$36.37

0.57 (1.59%)

FOXA

21st Century Fox

$36.73

0.53 (1.46%)

LGF.A

Lionsgate

$33.71

0.43 (1.29%)

DIS

Disney

$112.47

1.48 (1.33%)

VIAB

Viacom

$33.76

2.95 (9.57%)

VIA

Viacom

$39.10

3.45 (9.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

FNSR

Finisar

$22.74

0.48 (2.16%)

18:41
01/15/18
01/15
18:41
01/15/18
18:41
Downgrade
Finisar rating change at Goldman Sachs »

Finisar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADTN

Adtran

18:41
01/15/18
01/15
18:41
01/15/18
18:41
Upgrade
Adtran rating change at Goldman Sachs »

Adtran upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

CIEN

Ciena

$21.94

0.06 (0.27%)

18:40
01/15/18
01/15
18:40
01/15/18
18:40
Upgrade
Ciena rating change at Goldman Sachs »

Ciena upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$40.35

-0.705 (-1.72%)

18:36
01/15/18
01/15
18:36
01/15/18
18:36
Periodicals
Auto1 says no need for IPO following SoftBank investment, Reuters reports »

Auto1 said a $561M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$22.07

0.33 (1.52%)

18:32
01/15/18
01/15
18:32
01/15/18
18:32
Hot Stocks
FDA approves Teva's Trisenox injection for Acute Promyelocytic Leukemia »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

, GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

18:26
01/15/18
01/15
18:26
01/15/18
18:26
Periodicals
Google relaunching map service in China, Nikkei reports »

Google has relaunched its…

GOOG

Alphabet

$1,122.26

16.74 (1.51%)

GOOGL

Alphabet Class A

$1,130.65

18.6 (1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 18

    Mar

AAPL

Apple

$177.09

1.81 (1.03%)

, TCEHY

Tencent

$56.92

1.565 (2.83%)

18:24
01/15/18
01/15
18:24
01/15/18
18:24
Periodicals
Apple, Tencent reach deal to allow WeChat users dole out tips, WSJ says »

Apple (AAPL) and Tencent…

AAPL

Apple

$177.09

1.81 (1.03%)

TCEHY

Tencent

$56.92

1.565 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

RDS.A

Royal Dutch Shell

$70.88

1.04 (1.49%)

, RDS.B

Royal Dutch Shell

$72.70

0.97 (1.35%)

18:20
01/15/18
01/15
18:20
01/15/18
18:20
Periodicals
Shell acquires stake in solar energy company, Axios reports »

Royal Dutch Shell has…

RDS.A

Royal Dutch Shell

$70.88

1.04 (1.49%)

RDS.B

Royal Dutch Shell

$72.70

0.97 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$76.84

1.28 (1.69%)

18:17
01/15/18
01/15
18:17
01/15/18
18:17
Periodicals
Citi to raise pay for women, minorities, Reuters reports »

Citigroup will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

18:10
01/15/18
01/15
18:10
01/15/18
18:10
Periodicals
Fiat Chrysler CEO rules out selling Jeep business, splitting up, WSJ reports »

Fiat Chrysler CEO Sergio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$8.08

0.13 (1.64%)

18:06
01/15/18
01/15
18:06
01/15/18
18:06
Hot Stocks
SSR Mining reports production of over 370,000 gold equivalent ounces in 2017 »

SSR Mining said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$87.52

0.59 (0.68%)

17:57
01/15/18
01/15
17:57
01/15/18
17:57
Hot Stocks
Exxon Mobil encounters hydrocarbons onshore Papua New Guinea »

ExxonMobil announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEF

Central Fund of Canada Ltd

$13.68

0.23 (1.71%)

17:56
01/15/18
01/15
17:56
01/15/18
17:56
Hot Stocks
Central Fund of Canada Ltd, Sprott announce plan of arrangement closing date »

Central Fund of Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJR

New Jersey Resources

$39.45

-0.1 (-0.25%)

17:52
01/15/18
01/15
17:52
01/15/18
17:52
Hot Stocks
Adelphia files application for certificate of public convenience and necessity »

Following the conclusion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 25

    Jun

NOK

Nokia

$4.87

0.05 (1.04%)

17:49
01/15/18
01/15
17:49
01/15/18
17:49
Hot Stocks
Nokia wins five-year managed services agreement to manage Optus' network »

Nokia and Optus have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSTR

MicroStrategy

$139.75

1.39 (1.00%)

, AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

17:47
01/15/18
01/15
17:47
01/15/18
17:47
Hot Stocks
MicroStrategy announces rollout of MicroStrategy Partner Program »

MicroStrategy (MSTR)…

MSTR

MicroStrategy

$139.75

1.39 (1.00%)

AMZN

Amazon.com

$1,305.20

28.52 (2.23%)

MSFT

Microsoft

$89.60

1.52 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 31

    Jan

  • 07

    Feb

  • 18

    Mar

DAR

Darling Ingredients

$19.15

0.41 (2.19%)

17:37
01/15/18
01/15
17:37
01/15/18
17:37
Hot Stocks
Darling Ingredients announces new CFO, Chief Administrative Officer »

Darling Ingredients…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AON

Aon plc

$136.55

1.28 (0.95%)

17:34
01/15/18
01/15
17:34
01/15/18
17:34
Hot Stocks
Aon declares quarterly dividend of 36c per share »

Aon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$20.59

0.39 (1.93%)

17:32
01/15/18
01/15
17:32
01/15/18
17:32
Hot Stocks
KBR assures no disruptions on U.K. defense project »

KBR announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 25

    Jun

TRQ

Turquoise Hill

$3.57

0.06 (1.71%)

17:30
01/15/18
01/15
17:30
01/15/18
17:30
Hot Stocks
Turquoise Hill announces that Oyu Tolgoi received $155M Tax Act »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.